{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "467",
                "486"
            ],
            "subtype": "Investigation",
            "type": "T",
            "value": "badania izotopowego"
        },
        {
            "identifier": "T2",
            "position": [
                "650",
                "659"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Cefazolin"
        },
        {
            "identifier": "T3",
            "position": [
                "661",
                "664"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "ANA"
        },
        {
            "identifier": "T4",
            "position": [
                "666",
                "674"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Midanium"
        },
        {
            "identifier": "T5",
            "position": [
                "676",
                "695"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "znieczulenie og\u00f3lne"
        },
        {
            "identifier": "T6",
            "position": [
                "699",
                "702"
            ],
            "subtype": "Investigation",
            "type": "T",
            "value": "TEE"
        },
        {
            "identifier": "T7",
            "position": [
                "842",
                "861"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "wrodzon\u0105 wad\u0105 serca"
        },
        {},
        {
            "identifier": "T8",
            "position": [
                "333",
                "417"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "Dalsza opieka kardiologiczna - konieczne skierowanie do Poradni Kardiologicznej ICZM"
        },
        {
            "icd": "ICD10:Q20",
            "identifier": "N1",
            "referenced": "T7",
            "subtype": "Reference",
            "type": "N",
            "value": "Wrodzone wady rozwojowe jam i po\u00c5\u0082\u00c4\u0085cze\u00c5\u0084 sercowych"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 15 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: \u017ce\u0144ska\n------------------------------------------------\n------------------------------------------------\nZalecenia\n------------------------------------------------\n1. Dalsza opieka kardiologiczna - konieczne skierowanie do Poradni Kardiologicznej ICZMP.\n2. Do ustalenia w trybie ambulatoryjnym termin badania izotopowego w Zak\u0142adzie Medycyny Nuklearnej UM w \u0141odzi.\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nCefazolin, ANA, Midanium, znieczulenie og\u00f3lne do TEE.\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nDziewczynka z wrodzon\u0105 wad\u0105 serca przyj\u0119ta do Kliniki do poszerzonych bada\u0144 i ustalenia dalszego post\u0119powania Stan do\u015b\u0107 dobry\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nPotas: K:4.10[mmol/L]\nS\u00f3d: Na:145.00[mmol/L]\nRKZ Parametry krytyczne\n    pH:7.371\n    pCO2:42.6[mmHg]\n    BE:-0.80[mmol/L]\n    HCO3:24.1[mmol/L]\n    pO2:36.2[mmHg]\n    O2Sat:64.2[%]\n    COMMENT_HL7:\nMorfologia\n    WBC:8.27[10\\\\^3/ul]\n    RBC:4.94[10\\\\^6/ul]\n    HGB:15.5[g/dl]\n    HCT:43.2[%]\n    MCV:87.4[fl]\n    MCH:31.4[pg]\n    MCHC:35.9[g/dl]\n    PLT:305.0[10\\\\^3/ul]\n    RDW-SD:39.6[fl]\n    RDW-CV:12.3[%]\n    PDW:10.4[fl]\n    MPV:9.6[fl]\n    P-LCR:21.1[%]\n    PCT:0.3[%]\n    NEUTR#:4.03[10\\\\^3/ul]\n    NEUTR%:48.7[%]\n    LYMPH#:3.15[10\\\\^3/ul]\n    LYMPH%:38.1[%]\n    MONO#:0.75[10\\\\^3/ul]\n    MONO%:9.10[%]\n    EO#:0.30[10\\\\^3/ul]\n    EO%:3.60[%]\n    BASO#:0.04[10\\\\^3/ul]\n    BASO%:0.50[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nABL Parametry krytyczne\n    pH:7.347\n    pCO2:50.8[mmHg]\n    BE:0.80[mmol/L]\n    HCO3:27.1[mmol/L]\n    pO2:41.0[mmHg]\n    O2Sat:72.3[%]\n    Na - ABL:143[mmol/L]\n    K - ABL:4.3[mmol/L]\n    Cl - ABL:108[mmol/L]\n    Ca zj ABL:1.26[mmol/L]\n    Ht - ABL:53.8[%]\n    Hb ABL:17.6[g/dl]\n    FO2Hb:71.3[%]\n    FCOHb:0.9[%]\n    FMetHb:0.5[%]\n    FHbF - ABL:0.00[%]\n    GLU-ABL:93[mg/dl]\n    mleczany:25[mg/dl]\n    COMMENT_HL7:\nImmununochemia -Immulite: COMMENT_HL7:\nD-dimery t. ilo\u015bciowy: D-dimer:125.0[ng/ml]\nPLT -  z koagulogramu: PLT-KOAG:243.0[10\\\\^3/ul]\nFibrynogen (F): FIB:3.20[g/L]\nAntytrombina III (ATIII): ATIII:143.0[%]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:28.7[s]\nINR: INR:1.1\nCzas protrombinowy (PT): PT:11.8[s]\nCzas trombinowy (TT): TT:14.1[s]\nWap\u0144 ca\u0142kowity: Ca:2.60[mmol/L]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nWska\u017anik PT: PT%:93[%]\nKreatynina: CREA:0.60[mg/dl]\nMocznik: UREA:31.00[mg/dl]\nASPAT: AST:26.00[IU/L]\nALAT: ALT:23.00[IU/L]\nPLT z morfologii: PLT:305.0[10\\\\^3/ul]\nNT- proBNP: NTpBNP:57.20[pg/ml]\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:117.0[ml/min/1,73m2]\nWzrost pacjenta: WzrostPac:170[cm]\neGFR (1-18r\u017c K) stand.wg.Schwartza  wsp. 0.550: eGFR 1-18K:155.8[ml/min/1,73m2]\nPr\u00f3ba zgodno\u015bci (kontrola grupy krwi biorcy)\n    NR-KS:K18/001041\n    DONACJA:Z510018004712\n------------------------------------------------\nICD10\n------------------------------------------------\nQ21.1\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n88.721\n89.602\nG21\nG25\n89.541\n------------------------------------------------"
}